Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • Food & Beverage • Healthcare (& Wellness) • Life Science |
Stages | Seed, Startup, Early Stage |
Investing | United States • United Kingdom • Germany • South Africa • Sweden • Hong Kong • Europe • Hungary • Asia |
The March Fund is a venture capital firm that specializes in equity investments, particularly targeting the BioTech, Food & Beverage, Healthcare & Wellness, and Life Science industries. They are known for their engagement in Seed, Startup, and Early Stage investment opportunities, functioning to contribute not only capital but also mentorship and strategic guidance to the burgeoning firms in these sectors. The fund operates from its headquarters at 135 Grand Street, 2nd Floor, New York, New York, 10013, United States, despite the initial description placing it in Hong Kong, indicating a potential global reach or a previous location. Their investment thesis seems to focus on companies that are working on early-stage developments in biotechnologies, machine intelligence, sustainable nutrition solutions, and the agriculture-food supply chain. This choice of sectors underscores a commitment to fostering innovation and addressing some of the most pressing challenges of our time such as health, well-being, and sustainable food production. With equity investment expertise, The March Fund aims to empower entrepreneurs who are at the forefront of scientific and technological advancements that can lead to transformative outcomes for society. They likely seek to add value not only through financial support but also by leveraging their knowledge, networks, and resources to accelerate the growth of their portfolio companies.